Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 675 Carcinoma, Non-Small-Cell Lung 322 Neoplasms 166 Breast Neoplasms 163 Lung Neoplasms 156 Urinary Bladder Neoplasms 154 Neoplasm Metastasis 139 Cholangiocarcinoma 108 Ovarian Neoplasms 103 Biliary Tract Neoplasms 89 Lymphoma, Large B-Cell, Diffuse 72 Nasopharyngeal Carcinoma 69 Lymphoma 66 Sarcoma 63 Recurrence 62 Gallbladder Neoplasms 60 Carcinoma, Transitional Cell 54 Triple Negative Breast Neoplasms 53 Hodgkin Disease 52 Colorectal Neoplasms 49 Fallopian Tube Neoplasms 47 Lymphoma, Non-Hodgkin 46 Adenocarcinoma 45 Bile Duct Neoplasms 40 Carcinoma, Ovarian Epithelial 31 Non-Muscle Invasive Bladder Neoplasms 30 Uterine Cervical Neoplasms 28 Carcinoma 28 Unspecified Adult Solid Tumor, Protocol Specific 27 Adenocarcinoma of Lung 27

Interventions

Fulvestrant 18 Letrozole 8 Anastrozole 6 Capecitabine 5 palbociclib 4 olaparib 4 Docetaxel 4 pyrotinib 3 exemestane 3 Paclitaxel 3 Goserelin 3 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 abemaciclib 2 Vinorelbine 2 Trastuzumab 2 Injections 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1 sonidegib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025880 2023-04-03

PANGEA

Spanish Breast Cancer Research Group

Phase 2 Completed

36 enrolled 28 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡